Cervix Carcinoma Clinical Trial
Official title:
Establish a New Noninvasive Diagnostic Model Based on Clinical Indicators to Evaluate the Vaginal Invasion in Cervical Cancer Patients
This study aims to develop a diagnostic nomogram based on clinical factors with the prediction values of vaginal invasion in cervical cancer to optimize the treatment plan and surgical procedures.
Vaginal invasion is a crucial index participant in cervical cancer tumor staging and prognosis prediction. However, the roles of vaginal invasion are overlooked in the literature, compared with those of lymph node metastasis and parametrial invasion. As far as we know, this study is novel to construct a nomogram to predict the probability of pathologic vaginal invasion occurrence. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01759355 -
Hybrid PET/MR in the Therapy of Cervical Cancer
|
||
| Completed |
NCT02206048 -
Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix
|
N/A | |
| Completed |
NCT01937650 -
Radiotherapy + Metronidazole vs Radiotherapy Alone In Improving Treatment Outcomes in Advanced Cervical Cancer in Uganda
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05910177 -
Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin
|
Phase 2 | |
| Recruiting |
NCT04652076 -
GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or Pembrolizumab
|
Phase 1/Phase 2 | |
| Completed |
NCT04626466 -
Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation
|